Adapt: Empowering and equipping health workers to manage PPH safely and confidently

Jhpiego Corporation
Organization Location: 
Baltimore, MD, USA

Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality and morbidity worldwide, representing one out of every four maternal deaths that occur annually. The tamponade-approach has proven 80-90% effective in PPH management, and can decrease the need for referral and advanced surgical care, as well as preserve the reproductive capacity of young women who experience PPH. The Adapt tamponade, proposed by Jhpiego, fills safety, performance, and affordability gaps of existing tamponade options, with the ultimate goal of making available an effective, inexpensive, easy-to-use intrauterine tamponade device, designed with, by, and for the frontline health workers who are often confronted with the challenges of managing PPH. Despite the lifesaving potential, there are no known internal balloon tamponade devices designed and intended specifically for resource-constrained settings. As an easy to use and affordable and reusable device, the Adapt allows for a paradigm shift in PPH management by enabling lower-skilled health workers to be successful in performing the tamponade technique safely and confidently, increasing the coverage of effective PPH management, and improving the overall treatment hierarchy with proven interventions.

See video